#pharmaceutical-litigation

[ follow ]
#patent-settlement #lipid-nanoparticle-technology #covid-19-vaccines #intellectual-property #moderna-stock
#patent-settlement
fromIPWatchdog.com | Patents & Intellectual Property Law
1 day ago
Intellectual property law

Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute

Genevant Sciences and Arbutus Biopharma settled patent litigation with Moderna for up to $2.5 billion over unauthorized lipid nanoparticle technology use in COVID-19 vaccines.
from24/7 Wall St.
1 day ago
Business

Moderna and Ross Stores Lead Stock Gainers on Wednesday

Moderna surges 8.9% after settling a $2.25 billion patent dispute with Arbutus and Genevant over lipid nanoparticle technology, eliminating future royalty obligations and litigation risks for its mRNA pipeline.
Business
from24/7 Wall St.
1 day ago

Moderna and Ross Stores Lead Stock Gainers on Wednesday

Moderna surges 8.9% after settling a $2.25 billion patent dispute with Arbutus and Genevant over lipid nanoparticle technology, eliminating future royalty obligations and litigation risks for its mRNA pipeline.
more#patent-settlement
[ Load more ]